A Safety and Efficacy Study of OnabotulinumtoxinA in Forehead and Glabellar Facial Rhytides

Completed · Phase 3 · Has a placebo group

Conditions studied: Forehead Rhytides, Glabellar Rhytides

In brief

This is a safety and efficacy study of onabotulinumtoxinA in subjects with forehead and glabellar facial rhytides (frown lines).

Key facts

Study ID
NCT02261467
Run by
Allergan
People needed
421
Starts
2014-10-21
Expected to finish
2016-04-26
Last updated by the study team
2019-01-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.